Comparison

IL21R Blocking Peptide (N-Term)

Item no. ABC-BP21861a
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Parrish-Novak J.,et al.Nature 408:57-63(2000).
Ozaki K.,et al.Proc. Natl. Acad. Sci. U.S.A. 97:11439-11444(2000).
Clark H.F.,et al.Genome Res. 13:2265-2270(2003).
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Mural R.J.,et al.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Interleukin-21 receptor,IL-21 receptor,IL-21R,Novel interleukin receptor,CD360,IL21R,NILR
Similar products IL21R, IL-21R, NILR, CD360, Interleukin-21 receptor, Novel interleukin receptor, IL-21 receptor
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence is selected from aa 151-165 of HUMAN IL21R
Bio Background
This is a receptor for interleukin-21.
Gene Name
IL21R
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close